CAPTRUST Financial Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-840
| Closed | -$56K | – | 4356 |
|
|
2022
Q2 | $56K | Sell |
840
-137
| -14% | -$9.13K | ﹤0.01% | 2661 |
|
|
2022
Q1 | $80K | Buy |
977
+917
| +1,528% | +$75.1K | ﹤0.01% | 2447 |
|
|
2021
Q4 | $9K | Sell |
60
-40
| -40% | -$6K | ﹤0.01% | 3806 |
|
|
2021
Q3 | $18K | Buy |
100
+57
| +133% | +$10.3K | ﹤0.01% | 3246 |
|
|
2021
Q2 | $7K | Sell |
43
-15
| -26% | -$2.44K | ﹤0.01% | 3731 |
|
|
2021
Q1 | $10K | Buy |
58
+8
| +16% | +$1.38K | ﹤0.01% | 3455 |
|
|
2020
Q4 | $11K | Buy |
+50
| New | +$11K | ﹤0.01% | 2541 |
|